At the Transformations Center for Weight Loss, we prioritize treatments that may give you the best results
Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery
Important considerations for ongoing treatment: Regular review with the prescribing healthcare professional is essential Treatment should be discontinued if no clear benefit is observed after an adequate trial period (typically 812 weeks) Do not delay seeking medical attention for new or worsening symptoms Be alert to red flag symptoms requiring urgent assessment, such as unexplained weight loss, persistent fever, chest pain, or suicidal thoughts Patients should maintain realistic expectations , recognising that robust evidence for clinical benefits remains limited
Exploring cheap compounded tirzepatide options might be a better starting point
Some areas, like blood sugar control and weight loss, are well established
Conclusion Mounjaro (Tirzepatide) is a promising treatment for Type 2 Diabetes and obesity, offering better blood sugar control and weight loss benefits